Global Homozygous Familial Hypercholesterolemia Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Homozygous Familial Hypercholesterolemia Treatment

• 1.1 Definition of Homozygous Familial Hypercholesterolemia Treatment
• 1.2 Homozygous Familial Hypercholesterolemia Treatment Segment by Type
  • 1.2.1 Global Homozygous Familial Hypercholesterolemia Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AEM-2802
  • 1.2.3 AEM-2814
  • 1.2.4 Alirocumab
  • 1.2.5 Evinacumab
  • 1.2.6 Others
• 1.3 Homozygous Familial Hypercholesterolemia Treatment Segment by Applications
  • 1.3.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Homozygous Familial Hypercholesterolemia Treatment Overall Market
  • 1.4.1 Global Homozygous Familial Hypercholesterolemia Treatment Revenue (2014-2025)
  • 1.4.2 Global Homozygous Familial Hypercholesterolemia Treatment Production (2014-2025)
  • 1.4.3 North America Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Homozygous Familial Hypercholesterolemia Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Homozygous Familial Hypercholesterolemia Treatment
• 2.3 Manufacturing Process Analysis of Homozygous Familial Hypercholesterolemia Treatment
• 2.4 Industry Chain Structure of Homozygous Familial Hypercholesterolemia Treatment

3 Development and Manufacturing Plants Analysis of Homozygous Familial Hypercholesterolemia Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Homozygous Familial Hypercholesterolemia Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Homozygous Familial Hypercholesterolemia Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Homozygous Familial Hypercholesterolemia Treatment Production and Capacity Analysis
• 4.2 Homozygous Familial Hypercholesterolemia Treatment Revenue Analysis
• 4.3 Homozygous Familial Hypercholesterolemia Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Homozygous Familial Hypercholesterolemia Treatment Regional Market Analysis

• 5.1 Homozygous Familial Hypercholesterolemia Treatment Production by Regions
  • 5.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Production by Regions
  • 5.1.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Regions
• 5.2 Homozygous Familial Hypercholesterolemia Treatment Consumption by Regions
• 5.3 North America Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.3.1 North America Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.3.2 North America Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Homozygous Familial Hypercholesterolemia Treatment Import and Export
• 5.4 Europe Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.4.1 Europe Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.4.2 Europe Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Homozygous Familial Hypercholesterolemia Treatment Import and Export
• 5.5 China Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.5.1 China Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.5.2 China Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Homozygous Familial Hypercholesterolemia Treatment Import and Export
• 5.6 Japan Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.6.1 Japan Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.6.2 Japan Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Homozygous Familial Hypercholesterolemia Treatment Import and Export
• 5.7 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.7.1 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.7.2 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Import and Export
• 5.8 India Homozygous Familial Hypercholesterolemia Treatment Market Analysis
  • 5.8.1 India Homozygous Familial Hypercholesterolemia Treatment Production
  • 5.8.2 India Homozygous Familial Hypercholesterolemia Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Homozygous Familial Hypercholesterolemia Treatment Import and Export

6 Homozygous Familial Hypercholesterolemia Treatment Segment Market Analysis (by Type)

• 6.1 Global Homozygous Familial Hypercholesterolemia Treatment Production by Type
• 6.2 Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Type
• 6.3 Homozygous Familial Hypercholesterolemia Treatment Price by Type

7 Homozygous Familial Hypercholesterolemia Treatment Segment Market Analysis (by Application)

• 7.1 Global Homozygous Familial Hypercholesterolemia Treatment Consumption by Application
• 7.2 Global Homozygous Familial Hypercholesterolemia Treatment Consumption Market Share by Application (2014-2019)

8 Homozygous Familial Hypercholesterolemia Treatment Major Manufacturers Analysis

• 8.1 CymaBay Therapeutics Inc
  • 8.1.1 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.1.2 CymaBay Therapeutics Inc Product Introduction, Application and Specification
  • 8.1.3 CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Daewoong Co Ltd
  • 8.2.1 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.2.2 Daewoong Co Ltd Product Introduction, Application and Specification
  • 8.2.3 Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Gemphire Therapeutics Inc
  • 8.3.1 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.3.2 Gemphire Therapeutics Inc Product Introduction, Application and Specification
  • 8.3.3 Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 LipimetiX Development Inc
  • 8.4.1 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.4.2 LipimetiX Development Inc Product Introduction, Application and Specification
  • 8.4.3 LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Regeneron Pharmaceuticals Inc
  • 8.5.1 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.5.2 Regeneron Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 RegenxBio Inc
  • 8.6.1 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.6.2 RegenxBio Inc Product Introduction, Application and Specification
  • 8.6.3 RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 The Medicines Company
  • 8.7.1 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Production Sites and Area Served
  • 8.7.2 The Medicines Company Product Introduction, Application and Specification
  • 8.7.3 The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Homozygous Familial Hypercholesterolemia Treatment Market

• 9.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Trend Analysis
  • 9.1.1 Global Homozygous Familial Hypercholesterolemia Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Homozygous Familial Hypercholesterolemia Treatment Regional Market Trend
  • 9.2.1 North America Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
  • 9.2.2 Europe Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
  • 9.2.3 China Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
  • 9.2.4 Japan Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
  • 9.2.6 India Homozygous Familial Hypercholesterolemia Treatment Forecast 2019-2025
• 9.3 Homozygous Familial Hypercholesterolemia Treatment Market Trend (Product Type)
• 9.4 Homozygous Familial Hypercholesterolemia Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Homozygous Familial Hypercholesterolemia Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List